trk-700
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2016 (NCT02701374)
Timeline
Indications
Mechanism of action
- Cyclooxygenase-1INHIBITOR
PTGS1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- trk-700
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03043248 | Phase 1 | Feb 6, 2017 | Toray Industries, Inc |
| NCT02701374 | Phase 2 | Mar 1, 2016 | Toray Industries, Inc |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Toray Industries, Inc | For profit | 2 | 2 | 2 | 2016 |
1 organizations
Page 1 / 1